| abstract |
smR-78, a novel miRNA of the present invention, can increase the efficiency as a stem cell therapeutic agent by being used as a material or composition to enhance the function of mesenchymal stem cells based on the improvement of the cell proliferation rate, and furthermore, It can be usefully utilized as a specific indicator for aging and proliferation. In addition, since it can be used as a biomarker for lung cancer diagnosis, it can be usefully used as an active ingredient for lung cancer prevention and treatment, or lung cancer growth inhibitory agent. |